Talazoparib and radiation enhance the senolytic efficacy of venetoclax in therapy-induced senescent triple-negative breast cancer cells

Sultan Almudimeegh; Mashal M. Almutairi; Abrar Softah; Khalid Alhazzani; Lama Binobaid; Musaad Alshammari; Homood M. As Sobeai; Tareq Saleh; Moureq R. Alotaibi; Ali Alhoshani

doi:10.1007/s44446-025-00034-2

Citations

386

Views

Abstract not available for this publication.

Cite this Article (APA)

Sultan, A., Mashal, M. A., Abrar, S., Khalid, A., Lama, B., Musaad, A., Homood, M. A. S., Tareq, S., Moureq, R. A., Ali, A. (2025). Talazoparib and radiation enhance the senolytic efficacy of venetoclax in therapy-induced senescent triple-negative breast cancer cells. Saudi Pharmaceutical Journal. https://doi.org/10.1007/s44446-025-00034-2